CMP-002 for nervous system diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Nov 2026: Trial registered, NCT07935135

The trials

NCT07935135: Study of CMP-002 in Participants With SYNGAP1-Related Disorder

State
Not started
Phase
Phase 1 and Phase 2
People
80 planned
Started
Nov 2026
Primary completion
Jan 2029
Arms
CMP-002 Multiple Ascending Dose (MAD)
Results
None posted
  1. 13 Nov 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.